Medical Condition News

RSS

Stowers investigators define factors that regulate size of cellular fat pools

As the national waistline expands, so do pools of intra-cellular fat known as lipid droplets. Although most of us wish our lipid droplets would vanish, they represent a cellular paradox: on the one hand droplets play beneficial roles by corralling fat into non-toxic organelles. On the other, oversized lipid droplets are associated with obesity and its associated health hazards.

30 Aug 2012

Residency cap may hamper efforts to expand number of doctors

Bloomberg examines the need for more primary care physicians and the limit on the number of slots for training doctors.

30 Aug 2012

UAB Center of Research Translation to improve health of patients with gout, hyperuricemia

The University of Alabama at Birmingham is establishing a Center of Research Translation to improve the health of an increasing number of patients with gout and hyperuricemia.

30 Aug 2012

New York State Department of Health issues license to Veracyte's Afirma Gene Expression Classifier

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company, today announced that the New York State Department of Health has issued a license enabling Veracyte's Afirma Gene Expression Classifier to be offered to patients in the state.

30 Aug 2012

MU medicinal chemists create more potent, efficient weapon against cancer

Legend has it that Ralph Waldo Emerson once said, "Build a better mousetrap, and the world will beat a path to your door." University of Missouri researchers are doing just that, but instead of building mousetraps, the scientists are targeting cancer drugs. In a new study, MU medicinal chemists have taken an existing drug that is being developed for use in fighting certain types of cancer, added a special structure to it, and created a more potent, efficient weapon against cancer.

30 Aug 2012

EHRA White Book reports on current status of arrhythmia treatments in 54 ESC member countries

The analysis was conducted using five editions of the EHRA White Book, which is produced by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC).

30 Aug 2012

Bradykinesia in Parkinson’s disease: an interview with Dr. Joseph Giuffrida, President of Great Lakes NeuroTechnologies

Currently in the United States, there are over 1.5 million people living with Parkinson's and 50,000 new cases reported each year

30 Aug 2012

IQWiG examines added benefit of belimumab for patients with systemic lupus erythematosus

Belimumab has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). Products (AMNOG).

30 Aug 2012

University of Adelaide researchers to produce better quality pasta with health properties

University of Adelaide researchers are working with colleagues in Italy to produce better quality pasta that also adds greater value to human health.

30 Aug 2012

Headphones can damage coating of nerve cells and lead to temporary deafness

Turning the volume up too high on your headphones can damage the coating of nerve cells, leading to temporary deafness; scientists from the University of Leicester have shown for the first time.

30 Aug 2012

RegeneRx’s Thymosin Beta 4 can promote recovery of diabetic peripheral neuropathy

RegeneRx Biopharmaceuticals, Inc. reports that U.S. researchers have found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice including recovery of neurovascular dysfunction in the sciatic nerve and recovery of neurological function.

30 Aug 2012

UH pharmacologist examines age-related oxidative, inflammatory stress

Gaining new insight to managing sodium balance and blood pressure, investigators at the University of Houston (UH) College of Pharmacy believe their work may identify future therapeutic targets to control hypertension.

30 Aug 2012

Southampton Traffic Light test could easily diagnose liver fibrosis and cirrhosis

A new 'traffic light' test devised by Dr Nick Sheron and colleagues at University of Southampton and Southampton General Hospital could be used in primary care to diagnose liver fibrosis and cirrhosis in high risk populations more easily than at present.

30 Aug 2012

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

A study published in the most recent issue of the Journal of the American Medical Association (JAMA) presented encouraging news regarding physicians' ability to determine blood flow and associated coronary artery disease (CAD) using noninvasive CT scanning technology.

30 Aug 2012

Octogenarians have better survival rates following heart valve surgery

Octogenarians need not shy away from heart valve surgery because of their age; however, those sent home following surgery do better than those discharged to care facilities, according to an observational study published in the September 2012 issue of The Annals of Thoracic Surgery.

30 Aug 2012

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Norman H. Lee, Ph.D., professor of pharmacology at the George Washington University School of Medicine and Health Sciences (SMHS), received a total of $405,001 in grant funding from the National Institute on Drug Abuse (NIDA) to continue to study the correlation between genetics and susceptibility to drug abuse.

30 Aug 2012

Johns Hopkins team creates synthetic protein that can help locate tumors

Johns Hopkins researchers have created a synthetic protein that, when activated by ultraviolet light, can guide doctors to places within the body where cancer, arthritis and other serious medical disorders can be detected.

30 Aug 2012

CCE, Accretive Health partner to develop novel oncology care management

Accretive Health, Inc., a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.

30 Aug 2012

Combination of POZEN’s PA32540 and clopidogrel results in greater antiplatelet effects

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced the presentation of Phase 1 data, at the European Society of Cardiologists 2012 Congress, from a study of PA32540, a novel coordinated-delivery tablet of enteric-coated (EC) aspirin (325 mg) and immediate-release (IR) omeprazole (40 mg).

30 Aug 2012

Protalex announces results from PRTX-100 Phase 1b trial on active rheumatoid arthritis

Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed Phase 1b randomized, multiple-dose, dose-escalation study.

30 Aug 2012

Medical Condition News

Stowers investigators define factors that regulate size of cellular fat pools

Residency cap may hamper efforts to expand number of doctors

UAB Center of Research Translation to improve health of patients with gout, hyperuricemia

New York State Department of Health issues license to Veracyte's Afirma Gene Expression Classifier

MU medicinal chemists create more potent, efficient weapon against cancer

EHRA White Book reports on current status of arrhythmia treatments in 54 ESC member countries

Bradykinesia in Parkinson’s disease: an interview with Dr. Joseph Giuffrida, President of Great Lakes NeuroTechnologies

IQWiG examines added benefit of belimumab for patients with systemic lupus erythematosus

University of Adelaide researchers to produce better quality pasta with health properties

Headphones can damage coating of nerve cells and lead to temporary deafness

RegeneRx’s Thymosin Beta 4 can promote recovery of diabetic peripheral neuropathy

UH pharmacologist examines age-related oxidative, inflammatory stress

Southampton Traffic Light test could easily diagnose liver fibrosis and cirrhosis

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

Octogenarians have better survival rates following heart valve surgery

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Johns Hopkins team creates synthetic protein that can help locate tumors

CCE, Accretive Health partner to develop novel oncology care management

Combination of POZEN’s PA32540 and clopidogrel results in greater antiplatelet effects

Protalex announces results from PRTX-100 Phase 1b trial on active rheumatoid arthritis

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Latest News